NFKB1 and Cognitive impairment: Importantly, a previous study showed that treatment with SS‐31 significantly ameliorated isoflurane‐induced cognitive deficits and inflammatory responses by decreasing the levels of NF‐κB, NLPR3, and ROS (Wu et al., 2015).